Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 37: 144-153, 1991;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, J. J.
Right arrow Articles by Valdes, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, J. J.
Right arrow Articles by Valdes, R., Jr

Clinical Chemistry, Vol 37, 144-153, Copyright © 1991 by American Association for Clinical Chemistry

Approaches to minimizing interference by cross-reacting molecules in immunoassays

JJ Miller and R Valdes Jr
Department of Pathology, University of Louisville School of Medicine, KY 40292.

Here we review techniques useful in eliminating or reducing interferences caused by molecules that cross-react in immunoassays. The biochemical rationale for using these techniques is discussed. Examples are taken from recent studies aimed at reducing interferences caused by endogenous molecules such as digoxin-like immunoreactive factors or steroid hormones. In this context the role of protein-binding of cross- reacting molecules is also considered. Immunoassay ligand selectivity can be inherently limited by the heterogeneity of the antigenic response or by the structural similarity of epitopes on multiple ligands. Certain empirical approaches have proved useful in maximizing the analytical specificity of immunoassays. These approaches include isolating the relevant ligands before immunoassay, adjusting the kinetic or equilibrium conditions used during the assays, and developing more specific antisera. The physicochemical properties of the cross-reacting molecule best dictate which technique(s) to use. The approaches discussed here are general and apply to minimizing interference caused by a wide variety of both endogenous and exogenous cross-reacting molecules.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
P. A. Torjesen, L. Sandnes, and P. Boudou
Serum Testosterone in Women as Measured by an Automated Immunoassay and a RIA * Dr. Boudou responds for the authors of the article cited above:
Clin. Chem., March 1, 2004; 50(3): 678 - 679.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. J. Kricka
Interferences in Immunoassay--Still a Threat
Clin. Chem., August 1, 2000; 46(8): 1037 - 1038.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Scholer, J. Boecker, U. Engelmayer, K. Feldmann, D. Hannak, R. Kattermann, M. Oellerich, H. Raith, H. Schlebusch, H. Wieland, et al.
Comparability of a new turbidimetric digoxin test with other immunochemical tests and with HPLC—a multicenter evaluation
Clin. Chem., January 1, 1997; 43(1): 92 - 99.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Association for Clinical Chemistry.